Tag: osteogenesis imperfecta

Mereo BioPharma begins BPS-804 mid-stage trial in osteogenesis imperfecta

pharmanewsdaily- October 30, 2018

British specialty biopharma company Mereo BioPharma Group has wrapped up enrollment of patients for a phase 2b clinical trial that will evaluate its human monoclonal ... Read More